Vendor, Athens, GA
Innoveta Biomedical LLC
UEI HK8VNP32ANL7, CAGE 85CK6
1 award and -$133,550 obligated between September 27, 2024 and September 27, 2024, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | -$133,550 |
How it wins
Awards by competition, set-aside and type.
| Not Competed | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75D30120C09815Definitive Contract, September 27, 2024, Not Competed, 1 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Nitric Oxide Releasing Untra-Slippery Antibacterial Surfaces for Indwelling Catheter ApplicationsNAICS 541714, PSC AZ11 | -$133,550 |